Alıntılar

APA (7. basım) Alıntı
Li, R., Liu, X., Xu, Y., Zhao, J., Zhong, W., Gao, X., . . . Wang, M. (2024). Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report. Wiley.
Chicago Style (17. basım) Atıf
Li, Rongzhen, Xiaoyan Liu, Yan Xu, Jing Zhao, Wei Zhong, Xiaoxing Gao, Minjiang Chen, ve Mengzhao Wang. Remarkable Pathological Response to Neoadjuvant Tepotinib in Lung Adenocarcinoma with MET Exon 14 Skipping Mutation: A Case Report. Wiley, 2024.
MLA (9th ed.) Atıf
Li, Rongzhen, et al. Remarkable Pathological Response to Neoadjuvant Tepotinib in Lung Adenocarcinoma with MET Exon 14 Skipping Mutation: A Case Report. Wiley, 2024.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..